Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Gene therapy for keratin genodermatoses: striving forward but obstacles persist.

Bowden PE.

J Invest Dermatol. 2011 Jul;131(7):1403-5. doi: 10.1038/jid.2011.121.

2.

Peeling skin syndrome: genetic defects in late terminal differentiation of the epidermis.

Bowden PE.

J Invest Dermatol. 2011 Mar;131(3):561-4. doi: 10.1038/jid.2010.434.

3.

Defining the complex epithelia that comprise the canine claw with molecular markers of differentiation.

Bowden PE, Henderson H, Reilly JD.

Vet Dermatol. 2009 Oct;20(5-6):347-59. doi: 10.1111/j.1365-3164.2009.00851.x.

PMID:
20178471
4.

Epidermolysis bullosa simplex due to KRT5 mutations: mutation-related differences in cellular fragility and the protective effects of trimethylamine N-oxide in cultured primary keratinocytes.

Chamcheu JC, Virtanen M, Navsaria H, Bowden PE, Vahlquist A, Törmä H.

Br J Dermatol. 2010 May;162(5):980-9. doi: 10.1111/j.1365-2133.2009.09615.x. Epub 2010 Feb 1.

PMID:
20128788
5.

Mutations in a keratin 6 isomer (K6c) cause a type of focal palmoplantar keratoderma.

Bowden PE.

J Invest Dermatol. 2010 Feb;130(2):336-8. doi: 10.1038/jid.2009.395.

6.

Epidermolysis bullosa in calves in the United Kingdom.

Foster AP, Skuse AM, Higgins RJ, Barrett DC, Philbey AW, Thomson JR, Thompson H, Fraser MA, Bowden PE, Day MJ.

J Comp Pathol. 2010 May;142(4):336-40. doi: 10.1016/j.jcpa.2009.10.001. Epub 2009 Nov 11.

PMID:
19909967
7.

A novel mutation (p.Thr198Ser) in the 1A helix of keratin 5 causes the localized variant of epidermolysis bullosa simplex.

Bowden PE, Knight AG, Liovic M.

Exp Dermatol. 2009 Jul;18(7):650-2. doi: 10.1111/j.1600-0625.2008.00820.x. Epub 2009 Feb 8.

PMID:
19220453
8.

New consensus nomenclature for mammalian keratins.

Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DA, Rogers MA, Wright MW.

J Cell Biol. 2006 Jul 17;174(2):169-74. Epub 2006 Jul 10.

9.

Utilization of a cryptic noncanonical donor splice site in the KRT14 gene causes a mild form of epidermolysis bullosa simplex.

Han S, Cooper DN, Bowden PE.

Br J Dermatol. 2006 Jul;155(1):201-3. No abstract available.

PMID:
16792776
10.

Numerous keratinocyte subtypes involved in wound re-epithelialization.

Patel GK, Wilson CH, Harding KG, Finlay AY, Bowden PE.

J Invest Dermatol. 2006 Feb;126(2):497-502.

11.
12.

The human type II keratin gene cluster on chromosome 12q13.13: final count or hidden secrets?

Bowden PE.

J Invest Dermatol. 2005 Mar;124(3):xv-xvii. Review. No abstract available.

13.
14.
15.

Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression.

Virtanen M, Gedde-Dahl T Jr, Mörk NJ, Leigh I, Bowden PE, Vahlquist A.

Acta Derm Venereol. 2001 Jun-Jul;81(3):163-70.

16.

A novel keratin 5 mutation (K5V186L) in a family with EBS-K: a conservative substitution can lead to development of different disease phenotypes.

Liovic M, Stojan J, Bowden PE, Gibbs D, Vahlquist A, Lane EB, Komel R.

J Invest Dermatol. 2001 Jun;116(6):964-9.

17.

Two different mutations in the same codon of a type II hair keratin (hHb6) in patients with monilethrix.

Pearce EG, Smith SK, Lanigan SW, Bowden PE.

J Invest Dermatol. 1999 Dec;113(6):1123-7.

18.

Novel and recurrent mutations in keratin 10 causing bullous congenital ichthyosiform erythroderma.

McLean WH, Morley SM, Higgins C, Bowden PE, White M, Leigh IM, Lane EB.

Exp Dermatol. 1999 Apr;8(2):120-3.

PMID:
10232402
19.
20.

Characterization and chromosomal localization of human hair-specific keratin genes and comparative expression during the hair growth cycle.

Bowden PE, Hainey SD, Parker G, Jones DO, Zimonjic D, Popescu N, Hodgins MB.

J Invest Dermatol. 1998 Feb;110(2):158-64.

21.

A novel nonepidermolytic palmoplantar keratoderma: a clinical and histopathologic study of six cases.

Magro CM, Baden LA, Crowson AN, Bowden PE, Baden HP.

J Am Acad Dermatol. 1997 Jul;37(1):27-33.

PMID:
9216520
22.

A new keratin 2e mutation in ichthyosis bullosa of Siemens.

Jones DO, Watts C, Mills C, Sharpe G, Marks R, Bowden PE.

J Invest Dermatol. 1997 Mar;108(3):354-6.

23.

A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis.

Bickenbach JR, Longley MA, Bundman DS, Dominey AM, Bowden PE, Rothnagel JA, Roop DR.

Differentiation. 1996 Dec;61(2):129-39.

PMID:
8983179
24.

Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro.

Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN.

Br J Dermatol. 1995 Oct;133(4):501-11.

PMID:
7577575
25.

Mutation of a type II keratin gene (K6a) in pachyonychia congenita.

Bowden PE, Haley JL, Kansky A, Rothnagel JA, Jones DO, Turner RJ.

Nat Genet. 1995 Jul;10(3):363-5.

PMID:
7545493
26.

Birthmark due to cutaneous mosaicism for keratin 10 mutation.

Moss C, Jones DO, Blight A, Bowden PE.

Lancet. 1995 Mar 4;345(8949):596. No abstract available.

PMID:
7539878
27.

Sequence and expression of human hair keratin genes.

Bowden PE, Hainey S, Parker G, Hodgins MB.

J Dermatol Sci. 1994 Jul;7 Suppl:S152-63.

PMID:
7528047
28.
29.

Human bronchial epithelial cells transformed by the c-raf-1 and c-myc protooncogenes induce multidifferentiated carcinomas in nude mice: a model for lung carcinogenesis.

Pfeifer AM, Jones RT, Bowden PE, Mann D, Spillare E, Klein-Szanto AJ, Trump BF, Harris CC.

Cancer Res. 1991 Jul 15;51(14):3793-801.

30.

Transgenic mice. Gene expression and hair-loss.

Bowden PE.

Nature. 1990 Jul 26;346(6282):315. No abstract available.

PMID:
1695715
31.

Two type II keratin genes are localized on human chromosome 12.

Popescu NC, Bowden PE, DiPaolo JA.

Hum Genet. 1989 May;82(2):109-12.

PMID:
2470667
32.

Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA.

Woodworth CD, Bowden PE, Doniger J, Pirisi L, Barnes W, Lancaster WD, DiPaolo JA.

Cancer Res. 1988 Aug 15;48(16):4620-8.

33.

Expression and modification of keratins during terminal differentiation of mammalian epidermis.

Bowden PE, Stark HJ, Breitkreutz D, Fusenig NE.

Curr Top Dev Biol. 1987;22:35-68. Review. No abstract available.

PMID:
2443315
34.

Environmental induction of differentiation-specific keratins in malignant mouse keratinocyte lines.

Breitkreutz D, Hornung J, Pöhlmann J, Brown-Bierman L, Bohnert A, Bowden PE, Fusenig NE.

Eur J Cell Biol. 1986 Dec;42(2):255-67.

PMID:
2434329
35.

Proteolytic modification of acidic and basic keratins during terminal differentiation of mouse and human epidermis.

Bowden PE, Quinlan RA, Breitkreutz D, Fusenig NE.

Eur J Biochem. 1984 Jul 2;142(1):29-36.

36.

Differentiation specific functions in cultured and transplanted mouse keratinocytes: environmental influences on ultrastructure and keratin expression.

Breitkreutz D, Bohnert A, Herzmann E, Bowden PE, Boukamp P, Fusenig NE.

Differentiation. 1984;26(2):154-69.

PMID:
6203803
37.

Comparison of prekeratin and keratin polypeptides in normal and psoriatic human epidermis.

Bowden PE, Wood EJ, Cunliffe WJ.

Biochim Biophys Acta. 1983 Feb 28;743(1):172-9.

PMID:
6186286
38.

Prekeratin biosynthesis in human scalp epidermis.

Bladon PT, Bowden PE, Cunliffe WJ, Wood EJ.

Biochem J. 1982 Oct 15;208(1):179-87.

39.

Modification of human prekeratin during epidermal differentiation.

Bowden PE, Cunliffe WJ.

Biochem J. 1981 Oct 1;199(1):145-54.

40.

The effect of topically applied progesterone on sebum excretion rate.

Simpson NB, Bowden PE, Forster RA, Cunliffe WJ.

Br J Dermatol. 1979 Jun;100(6):687-92.

PMID:
157150
41.

Tolerance to the anti-seborrhoeic effect of topically applied progesterone [proceedings].

Simpson NB, Bowden PE, Cunliffe WJ, Forster RA.

Br J Dermatol. 1978 Jul;99(Suppl 16):9. No abstract available.

PMID:
151551
42.

Effect of alpha-melanocyte-stimulating hormone and testosterone on cutaneous and modified sebaceous glands in the rat.

Thody AJ, Cooper MF, Bowden PE, Meddis D, Shuster S.

J Endocrinol. 1976 Dec;71(3):279-88.

PMID:
1003058
43.

Effects of 5alpha-reduced androgens on preputial-gland size and lipogenic activity.

Bowden PE, Meddis D, Cooper MF, Thody AJ, Shuster S.

Biochem Soc Trans. 1976;4(4):795-7. No abstract available.

PMID:
1001770
44.

Proceedings: The sebaceous gland response to alpha-melanocyte-stimulating hormone and testosterone.

Thody AJ, Cooper MF, Meddis D, Bowden PE, Shuster S.

J Endocrinol. 1975 Nov;67(2):18P-19P. No abstract available.

PMID:
1206268
45.

Proceedings: Synergistic effects of testosterone and alpha-melanocyte-stimulating hormone on lipogenesis in rat preputial gland.

Cooper MF, Bowden PE, Thody AJ, Shuster S.

J Endocrinol. 1975 Mar;64(3):63P. No abstract available.

PMID:
1133555

Supplemental Content

Loading ...
Support Center